Skip to main content

Table 1 Effect of the non-ionic surfactant Tween 60: cholesterol with various molar ratios on entrapment efficiency (EE %), size and % release (R) in CUR/PTX loaded Niosomes

From: Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy

Code

Mole Tween 60 (%)

Mole cholesterol (%)

EE (%)

R (%)

Size (nm)

PDI

Zeta potential (mV)

F1

90

10

EE % CUR = 52.24 ± 0.47

EE % PTX = 45.24 ± 0.12

R % CUR = 75.26 ± 0.42

R % PTX = 65.14 ± 0.32

Size CUR = 101.5 ± 0.12

Size PTX = 122.4 ± 0.46

PDI CUR = 0.281 ± 0.056

PDI PTX = 0.261 ± 0.056

Zeta CUR = − 20.34 ± 0.68

Zeta PTX = − 16.62 ± 0.47

F2

80

20

EE % CUR = 66.12 ± 0.86

EE % PTX = 61.74 ± 0.36

R % CUR = 69.11 ± 0.24

R % PTX = 56.12 ± 0.66

Size CUR = 107.5 ± 0.31

Size PTX = 131.24 ± 0.31

PDI CUR = 0.246 ± 0.12

PDI PTX = 0.236 ± 0.12

Zeta CUR = − 22.41 ± 0.75

Zeta PTX = − 19.08 ± 0.36

F3

75

25

EE % CUR = 81.24 ± 0.47

EE % PTX = 72.44 ± 0.63

R % CUR = 57.26 ± 0.11

R % PTX = 47.24 ± 0.36

Size CUR = 112.7 ± 0.64

Size PTX = 140.66 ± 0.72

PDI CUR = 0.224 ± 0.087

PDI PTX = 0.214 ± 0.087

Zeta CUR = − 21.38 ± 0.86

Zeta PTX = − 21.54 ± 0.44

F4

70

30

EE % CUR = 85.42 ± 0.11

EE % PTX = 81.37 ± 0.21

R % CUR = 46.11 ± 0.34

R % PTX = 39.22 ± 0.41

Size CUR = 118.7 ± 0.56

Size PTX = 149.32 ± 0.65

PDI CUR = 0.204 ± 0.062

PDI PTX = 0.194 ± 0.062

Zeta CUR = − 21.45 ± 0.42

Zeta PTX = − 19.56 ± 0.27

F5

50

50

EE % CUR = 71.24 ± 0.16

EE % PTX = 67.12 ± 0.47

R % CUR = 54.12 ± 0.22

R % PTX = 45.14 ± 0.32

Size CUR = 125.1 ± 0.44

Size PTX = 157.44 ± 0.66

PDI CUR = 0.214 ± 0.013

PDI PTX = 0.208 ± 0.013

Zeta CUR = − 24.16 ± 0.22

Zeta PTX = − 24.56 ± 0.42